A hemangioma that rapidly increases in size has the potential to trap platelets and cause a consumptive coagulopathy. We describe the case of an 18-week-old boy who was brought to a local emergency department with ecchymosis on his nasal bridge and medial epicanthi, as well as a subconjunctival hemorrhage. He was noted to be
Introduction
Hemangiomas and other vascular tumors usually present at birth. These lesions are relatively common, being observed in 4 to 12% of infants during their first year of life. 1 Lesions that rapidly increase in size have the potential to trap platelets, resulting in a consumptive coagulopathy. Such tumors have historically been associated with a high mortality rate (37%) in children. 2 In addition to the thrombocytopenia associated with the rapid growth of a lesion, hypofibrinogenemia and deterioration of labile coagulation factors contribute to the bleeding tendency. 3 A consumptive coagulopathy in the presence of a vascular tumor defines Kasabach-Merritt syndrome (KMS). In 1940, Kasabach and Merritt described the first reported case of KMS, which occurred in a 2-month-old boy. 4 Their patient presented with an extensive capillary hemangioma of the thigh associated with severe consumptive coagulopathy. He responded rapidly to external irradiation and radium needle implantation.
It is now known that effective management of KMS requires both the maintenance of hemostasis and removal or ablation of the lesion. However, surgery is hazardous in the presence of a bleeding diasthesis. No single treatment is consistently successful, and several different modalities are generally required. 5 In this article, we report a new case of KMS that was successfully treated with a systemic corticosteroid, embolization, and vincristine. Resection was attempted, but it did not prove to be curative. We also describe the range of treatment modalities available and their limitations.
Case report
A boy was born by planned induction at 41 weeks' gestation. The delivery was uneventful, and the child did not require admission to the special care baby unit. He was the first child of nonconsanguineous parents. His mother had 3 children from a previous marriage, 2 of whom had pseudochondrodysplasia. There was no family history of hematologic disorders. Upper airway difficulties had been noticed since birth; they manifested as snoring at night and intermittent feeding difficulties.
Overnight oximetry performed electively demonstrated no significant desaturations, and at this stage treatment was not indicated.
At 18 weeks of age, the boy was brought to the emergency department of a local hospital with ecchymosis on his nasal bridge and medial epicanthi, as well as a subconjunctival hemorrhage. He had initially been treated at a district general hospital for idiopathic thrombocytopenic purpura after an increased level of megakaryocytes was discovered in his bone marrow aspirate. His platelet count had decreased at a rate faster than what is expected in a classic case of idiopathic thrombocytopenic purpura, and he required several platelet transfusions. Over the next 10 days, his condition deteriorated, and he was referred to our tertiary care center.
On examination at our institution, the patient's ecchymosis and petechiae had worsened, and a neck swelling in the right posterior triangle had become apparent, along with associated palpable cervical lymph nodes (figure 1). His clotting factors were supplemented. Computed tomography (CT) of the head and neck demonstrated a lobular soft-tissue-density mass in the right posterior triangle of the neck that extended to the level of the skull base. The mass measured 4.6 × 2.1 cm in its maximum dimensions. Associated bony irregularity was noted. The lesion was biopsied, and another platelet transfusion was administered. Histologic analysis of the biopsy specimen revealed a giant kaposiform hemangioma. In the presence of a consumptive coagulopathy, the patient was diagnosed with KMS.
Prednisolone was commenced and clotting factor and platelet transfusions were administered, but the tumor continued to expand (figure 2). Following an incisional biopsy, the child developed a subcutaneous hematoma and inspiratory stridor (figure 3). Intubation was required for 19 days. Throughout this period, the patient required regular correction of his coagulopathy and platelet support.
While the patient was intubated, imaging of the neck vessels was performed with T1-weighted magnetic resonance imaging (MRI), short T1 inversion recovery (STIR) MRI, and axial dual-echo magnetic resonance angiography. Findings included a very large, predominantly right-sided mass that extended to the partially eroded skull base and encased the right common carotid artery and the right vertebral artery. Medially, the mass extended into the spinal canal, where it compressed the right side of the thecal sac and displaced and compressed the spinal cord.
After discussions with the family and with interventional radiologists, embolization of the occipital and internal maxillary arteries was performed. Three days later, the patient was extubated, and he no longer required plasma, platelet, or cryotherapy support. However, after 10 days, his platelet count and clotting began to deteriorate again. A weekly dose of vincristine was commenced, and a follow-up MRI of the neck was obtained. When the MRI demonstrated a mass that was similar in size to the one seen on the initial scans, a second embolization was carried out on the posterior auricular artery, internal maxillary artery, and deep cervical arteries.
The next day, with the patient still intubated, a rightsided limb weakness and right divergent squint were noted. CT demonstrated a wedge-shaped area of low attenuation in the cerebellar peduncle that was consistent with an area of ischemia.
The patient was successfully decannulated 5 days after embolization. His coagulation profile improved with no additional support, and he underwent regular follow-up in the hematology outpatient department (figure 4). The weakness in his right upper and lower limbs improved with regular physiotherapy over the next 10 weeks, and his limb function returned to normal. The divergent squint resolved somewhat, and it was being monitored by the ophthalmology department. The vincristine was titrated down from weekly to fortnightly to monthly, and it was eventually stopped. He completed follow-up with no recurrence of disease.
Discussion
KMS is a rare disorder that can lead to a rapid escalation in the consumption of coagulation factors. It can result in disseminated intravascular coagulopathy and life-threatening hemorrhage. More than 80% of all cases occur within the first year of life. 6 Initially, the primary management goal is the maintenance of hemostasis, as most infants with KMS present with a platelet level of less than 20 × 10 9 /L and a drastically shortened platelet half-life. 5 Once hemostasis is achieved, treatment of the lesion must be instituted rapidly.
Several treatment options are available, including radiotherapy, steroid therapy, interferon, vincristine, and embolization.
Radiotherapy. Radiotherapy was the first treatment option described by Kasabach and Merritt 4 in their original report in 1940, and it was used frequently until the 1960s. It has been suggested that radiotherapy be used in a KMS patient with a life-threatening coagulopathy after corticosteroid treatment has failed. 7 An earlier retrospective analysis of 153 reported cases reached the same conclusion. 2 Steroids. Steroids produce variable responses in the treatment of hemangiomas. For example, in a series of 25 cases of extensive hemangioma studied by Enjolras et al, 23 patients received steroid treatment. 8 Of this group, 7 patients (30%) exhibited an excellent response to drug therapy, another 7 did not respond at all (complete treatment failure), and 9 patients (39%) experienced a moderate response-but one that did not alter the natural course of the disease. By contrast, the success rate for steroid treatment of cutaneous hemangiomas has been reported to be more than 90% in children younger than 1 year and more than 80% in children older than 1 year. 9 Interferon. Alfa interferon has been used to treat hemangiomas since 1989, when White et al published their report of its successful use in the treatment of a pulmonary hemangioma. 10 In 2002, Hesselmann et al reported the successful use of alfa interferon and radiotherapy (9.5 Gy in 5 fractions) to treat a 6-week-old boy with neonatal KMS after steroid therapy had failed to reverse the effects of a large, upper right cervical hemangioma. 7 However, interferon therapy is associated with constitutional and neurologic symptoms, 11 and its use is recommended only for large, complicated hemangiomas that are not responsive to steroid treatment. 12, 13 Vincristine. Large, case-controlled trials of vincristine for the treatment of KMS have not been undertaken, but several case studies and case reports have supported its efficacy. In a retrospective study of 15 infants across 9 institutions in the United States published in 2002, Haisley-Royster et al found that KMS treated solely with vincristine led to a successful resolution in all 15 cases; the average length of treatment was 21.5 weeks. 14 In 2009, Drucker et al described the successful treatment of a neonate with combination vincristine and steroid therapy over the course of 1 year; they concluded that it should be considered a first-line therapy for the treatment of KMS. 15 Two years earlier, Thomson et al reported a case series of 4 children with KMS who had not responded to steroid therapy; all 4 were effectively treated with vincristine, and none experienced any discernible side effects, further supporting its use as a first-line therapy. 16 Embolization. Large vascular tumors in the head and neck region are often unresectable at presentation as a result of the infiltration or enclosure of vital structures. Embolization has been shown to be effective (1) in re-ducing the size of vascular tumors sufficiently to make resection more practical and (2) as a definitive treatment following a course of steroid therapy. 17 Burrows et al published a series of 30 cases of vascular lesions in the head and neck in children who underwent urgent or emergent therapeutic embolization after complications (including airway compromise) became evident; they reported that embolization was successful in 28 of these cases (93%). 18 Komiyama et al published a report of a 2-month-old girl with a huge cervicofacial hemangioma who had not responded to 2 weeks of steroid treatment; the onset of airway compromise and deterioration of clotting factors prompted the use of arterial embolization, which led to rapid clinical improvement. 19 In conclusion, KMS is a rare disorder of childhood that is characterized by purpura and thrombocytopenia associated with a vascular tumor. Life-threatening hemorrhage may occur secondary to a consumptive coagulopathy caused by platelet trapping by the tumor. KMS poses a diagnostic and therapeutic challenge, as the vascular tumor differs from the classic involuting hemangioma of infancy. 20 Although the response to treatment is variable, the tumor will involute if platelet consumption is arrested.
A finding of a consumptive coagulopathy associated with thrombocytopenia in an infant should alert the clinician to the possibility of KMS. Our case involved a difficult-to-control consumptive coagulopathy that was complicated by airway compromise, erosion of the skull base, and infiltration of the spinal canal. With the lesion deemed to be unresectable, eventual success was dependent on the maintenance of hemostasis, initial medical treatment with a steroid, repeat embolization, and longer-term control with vincristine.
